9
GROWING THE RESPONSIBLE USE OF MEDICINES
COLLABORATIONS AND PARTNERSHIPS
INVOLVING PATIENTS
If we are to achieve responsible use of medicines, patients
need to be on board. FIP has continued to work with patient
groups, particularly through the International Alliance of
Patients Organizations (IAPO). The immediate past-chair of
IAPO, was invited to speak at our Dublin congress, but FIP
officers have also reached out to patient groups through
taking part in their events. In December, for example, FIP
vice- president Prafull Sheth attended an IAPO event Meeting
patients needs in South-East Asia effective strategies for
improving patient safety .
WORKING TOWARDS INTERPROFESSIONAL COLLABORATION
The concept of responsible medicines use is wider than rational use.
It requires that all actors are engaged. In May 2013, FIP joined with
other leading health professions, under the umbrella of the World
Health Professions Alliance, to call for a new emphasis on colla bo-
rative practice through a major new statement. This stresses that
effective collaboration between different professions can improve
services, increase user involvement in decisions, improve use of
resources, reduce disability and raise job satisfaction of health
professionals.
The statement, launched during the 66th World Health Assembly,
called on governments to fund structures that support
interprofessional collaborative practice.
read more
read more
LEADING COLLABORATION ON ETHICS
Ensuring medicines are used in the right way is an
ethical obligation. Research and innovation must also
be ethical and transparent. In January 2014, FIP, together
with four global healthcare organisations, signed a
Consensus framework for ethical collaboration between
patients organisations, healthcare professionals and the
pharmaceutical industry.
FIP s special interest groups (SIGs) also had important
discussions about ethics. In July 2013, for example,
Hitoshi Sasaki, chair of the SIG on trans lational research
and individualised medicines, organised an international
workshop, held in Japan, focusing on the ethics of
health research and translational research.
VIGNETTES 2013/14